The two strain hybrid system was successfully tested using an early version of
"This early version of our hybrid system was tested specifically to confirm that we are on track for our spring trials," said company CEO and Founder
This advancement in the Company's commercialization of recombinant spider silk will significantly increase silk production per rearing cycle and will likely improve the quality of the finished silk.
The Company is now planning to transition all of its spider silk production to a two strain hybrid model in the near term. The Company hopes to be able to utilize even more advanced hybrids before the end of the upcoming field trials.
To view the most recent news from
About
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward-Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward-looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
(720) 288-8495
ir@KraigLabs.com
Source:
2023 GlobeNewswire, Inc., source